Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus

NCT01299012 · Completed

Last updated 2026-05-28

This clinical trial tests whether adding the medication liraglutide to standard treatment helps improve blood sugar control in adults with type 1 diabetes.

Status Completed The study has finished.

Type Observational

Participants 30 people

Who can join Ages 18–65 · all sexes

Timeline Started 2010-10 · est. completion 2013-06

What this study is testing ClinicalTrials.gov NCT01299012 ↗

Description as written by the study sponsor.

Evaluating the use of Liraglutide in patients with Type 1 Diabetes.

Treatments tested

Liraglutide also known as Victoza Drug

Liraglutide s/c 0.6mg once daily.

Main thing measured	Improved Blood Glucose comtrol in Type 1 Diabetes Patients with Liraglutide
Sponsor	University at Buffalo
Conditions studied	Type 1 Diabetes Mellitus
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01299012 ↗